↓ Skip to main content

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Overview of attention for article published in Cochrane database of systematic reviews, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter
7 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Published in
Cochrane database of systematic reviews, October 2018
DOI 10.1002/14651858.cd007360.pub3
Pubmed ID
Authors

Eu Chang Hwang, Shreyas Gandhi, Jae Hung Jung, Mari Imamura, Myung Ha Kim, Ran Pang, Philipp Dahm

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 16%
Student > Master 10 14%
Researcher 8 11%
Student > Ph. D. Student 7 9%
Student > Doctoral Student 6 8%
Other 17 23%
Unknown 14 19%
Readers by discipline Count As %
Medicine and Dentistry 25 34%
Nursing and Health Professions 9 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Social Sciences 5 7%
Engineering 3 4%
Other 8 11%
Unknown 16 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2019.
All research outputs
#3,433,742
of 14,944,712 outputs
Outputs from Cochrane database of systematic reviews
#5,865
of 11,056 outputs
Outputs of similar age
#95,417
of 323,638 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 92 outputs
Altmetric has tracked 14,944,712 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,056 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.